key: cord-0831789-3r8dunav authors: Gioia, Laura C.; Poppe, Alexandre Y.; Laroche, Roxanne; Dacier-Falque, Tristan; Sévigny, Isabelle; Daneault, Nicole; Deschaintre, Yan; Jacquin, Grégory; Stapf, Christian; Odier, Celine title: Streamlined Poststroke Treatment Order Sets During the SARS-CoV-2 Pandemic: Simplifying While Not Compromising Care date: 2020-08-13 journal: Stroke DOI: 10.1161/strokeaha.120.031008 sha: 50d087f840c3d5acd22a23f076cdf0791076c287 doc_id: 831789 cord_uid: 3r8dunav BACKGROUND AND PURPOSE: Standard poststroke treatment monitoring protocols are made problematic during the coronavirus disease 2019 (COVID-19) pandemic by the frequency of patient assessments, requiring repeated donning and doffing procedures in a short interval of time. METHODS: A streamlined poststroke treatment protocol was developed to limit frequency of patient encounters while maximizing the yield of each encounter by grouping together different components of poststroke care into single bedside visits. RESULTS: Streamlined order sets were developed late March 2020. During the first 6 weeks following implementation, 70 patients were admitted to a geographically defined designated warm COVID-19 unit with modified poststroke care order sets. Of these, 33 (47.1%) patients received acute reperfusion therapy. All but 3 patients evolved favorably with either stable or improving National Institutes of Health Stroke Scale at 24 hours. In the 3 patients who experienced early neurological deterioration, none were found to be attributable to insufficient patient monitoring. CONCLUSIONS: Adapting preexisting poststroke care protocols may be necessary while the risk of COVID-19 infection remains high. We propose a streamlined approach to facilitate poststroke monitoring in patients with stroke with unknown COVID status. S tandard poststroke treatment procedures require enhanced patient monitoring, particularly within the first hours following intravenous thrombolysis and endovascular thrombectomy. These procedures are often based on protocols used in the pivotal National Institute of Neurological Disorders and Stroke thrombolysis trial, although many elements in such order sets have never been studied in detail. 1 In the context of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, poststroke monitoring is made problematic by the frequency of patient assessments, requiring repeated donning and doffing procedures in a short interval of time. Recent stroke guidance papers recommend adherence to published guidelines regarding acute stroke therapy and postrecanalization monitoring but acknowledge that full compliance may be limited in regions as the pandemic evolves. 2, 3 The data that support the findings of this study are available from the corresponding author upon reasonable request. The Centre Hospitalier de l'Université de Montreal is a high-volume comprehensive stroke center in Montreal, Quebec, Canada, performing >300 thrombolysis and endovascular thrombectomy procedures annually. As of late March 2020, the city of Montreal became, and remains, the epicenter of the Canadian SARS-CoV-2 pandemic. Based on recommendations of the institutional infectious disease prevention and control team, patient encounters in patients with suspected or positive coronavirus disease 2019 (COVID-19) were to be minimized to a maximum of 4 patient encounters per 24 hours. Accordingly, in collaboration with stroke neurology and nursing staff, streamlined poststroke order sets were developed to minimize patient encounters while attempting to ensure adequate patient surveillance, particularly in the hours following reperfusion procedures where the risk of symptomatic post-thrombolysis intracranial hemorrhage is highest. 4 A recent small single-center single-arm study found that low-intensity monitoring following intravenous thrombolysis was safe. 5 Furthermore, the yield of each patient encounter was maximized by grouping together different components of poststroke care into single bedside visits (Table 1) . Streamlined order sets were used in patients admitted to a temporary stroke unit equivalent (a repurposed portion of the intensive care unit) while awaiting COVID-19 testing results to cohort warm patients and avoid contaminating staff from the main stroke unit. Information sessions and available support were available for nursing staff in these units by the interdisciplinary stroke team. COVID-19 testing was performed upon admission by nasopharyngeal swab in all patients, with results available within 24 hours after testing. Patients ultimately found to be COVID-negative were then transferred to the main stroke unit while patients with COVID-positive were transferred to a hot COVID unit. Poststroke imaging and workup, including repeat brain scan at 24 hours, was delayed until COVID status confirmation to mitigate risk of viral spread during patient transport to CT scan. However, in the event of neurological deterioration in patients with pending COVID status results, it was recommended to proceed with imaging without delay but with utilization of all appropriate precautions. Retrospective chart review for this study with waiver of consent was approved by our local institutional ethics committee. Streamlined order sets were developed late March 2020, and were available for use as of April 1, 2020. During the first 6 weeks following implementation, 95 patients were evaluated for suspected acute stroke at our institution. Of these, 33 (34.7%) patients received acute reperfusion therapy, and 70 patients with a diagnosis of neurovascular pathology were admitted to the warm COVID-19 stroke unit (patient characteristics are listed in Table 2 ). All but 3 patients evolved favorably with either stable or improving National Institutes of Health Stroke Scale/ Score at 24 hours. Of the 3 patients who experienced early neurological deterioration, 2 were patients with intracranial hemorrhage associated with anticoagulation use (multifocal intracranial hemorrhage on enoxaparin; and traumatic subdural hematoma on apixaban in a nonsurgical candidate) experienced hematoma expansion despite aggressive blood pressure management and anticoagulation reversal. The third patient experienced immediate deterioration postendovascular thrombectomy due to recurrent ipsilateral embolism to the M1 segment of the middle cerebral artery. The deterioration occurred while still in the angiography suite and before transfer to the warm unit and subsequently underwent a second mechanical thrombectomy. No deterioration was deemed attributable to insufficient monitoring from the lower-frequency, streamlined stroke order sets. Two of the 95 patients evaluated for suspected stroke tested positive for COVID-19. These 2 patients were, however, diagnosed with a stroke mimic and admitted to a COVID-19 warm unit other than the one assigned to patients with stroke. Modifications to preexisting poststroke care protocols may be necessary during the COVID-19 pandemic to balance adequate patient safety while mitigating risk of infectious exposure while the risk of COVID-19 infection remains high. We present a streamlined approach to facilitate poststroke monitoring in patients with stroke with unknown COVID status. coronavirus disease 2019 SARS-CoV-2 severe acute respiratory syndrome coronavirus-2 Tissue plasminogen activator for acute ischemic stroke Temporary emergency guidance to US Stroke Centers during the coronavirus disease (COVID-19) pandemic: on behalf of the American Heart Association/American Stroke Association Stroke Council Leadership Canadian Stroke Best Practices Advisory Council. Canadian stroke best practice guidance during the COVID-19 pandemic American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Quality of Care and Outcomes Research. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Safety trial of low-intensity monitoring after thrombolysis: optimal post Tpa-Iv monitoring in ischemic stroke (OPTIMIST) *Patients who were admitted with initial diagnosis of ischemic stroke but with final diagnosis of stroke mimic.